Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China · Delayed Price · Currency is CNY 5.22
-0.05 (-0.95%)
At close: Feb 6, 2026
SHA:600998 Revenue
Jointown Pharmaceutical Group had revenue of 38.22B CNY in the quarter ending September 30, 2025, with 5.41% growth. This brings the company's revenue in the last twelve months to 157.71B, up 5.70% year-over-year. In the year 2024, Jointown Pharmaceutical Group had annual revenue of 151.81B with 1.11% growth.
Revenue (ttm)
157.71B
Revenue Growth
+5.70%
P/S Ratio
0.17
Revenue / Employee
5.23M
Employees
30,169
Market Cap
26.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 151.81B | 1.67B | 1.11% |
| Dec 31, 2023 | 150.14B | 9.72B | 6.92% |
| Dec 31, 2022 | 140.42B | 18.02B | 14.72% |
| Dec 31, 2021 | 122.41B | 11.55B | 10.42% |
| Dec 31, 2020 | 110.86B | 11.36B | 11.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |